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Hyperlipidemia is a lipid metabolism disorder characterized by an 
increase in serum lipid levels. Hyperlipidemia is a major risk factor for            
many metabolic syndrome diseases because it triggers oxidative stress. 
Oxidative stress can be reduced by endogenous antioxidant enzymes 
triggered by exogenous antioxidant compounds, such as 7-OH-2- (4-OH-3-
methoxyphenyl)-chroman-4-one isolated from the seeds of Swietenia 
macrophylla King. The aims of this study were to investigate the effects of 7-
OH-2-(4-OH-3-methoxyphenyl)-chroman-4-one compounds on cholesterol 
level, LDL level, Mn-SOD levels and SOD2 gene expression of              
hyperlipidemic rats. Thirty rats (Rattus norvegicus ) were divided into 6 
groups, normal group (N), hyperlipidemia group (HL), hyperlipidemia group 
with simvastatin (P), hyperlipidemic group with 7-OH-2-(4-OH-3-
methoxyphenyl)-chroman-4-one with dose 10 (F10), 30 (F30) and 90 (F90) 
mg/200g body weight (BW). Cholesterol and LDL were analyzed with CHOD-
PAP method, Mn-SOD level was analyzed by ELISA method and SOD2 gene 
expression was analyzed by qPCR method. The decrease in cholesterol and 
LDL levels were most prevalent in group F90 with dose 90mg/200g BW of 7-
OH-2-(4-OH-3-methoxyphenyl)-chroman-4-one, with average difference 
each of them was 172.43mg/dL and 36.12mg/dL. The rats fed on high-
cholesterol diet exhibited a significant elevation in Mn-SOD levels (p<0.05) 
compared to normal group. The treated animals with 7-OH-2-(4-OH-3-
methoxyphenyl)-chroman-4-one has the level of Mn-SOD is significantly 
lower (p<0.05) compared with hyperlipidemic group. Expression of SOD2 in 
group F90 has value close to normal group (p>0.05). 7-OH-2-(4-OH-3-
methoxyphenyl)-chroman-4-one with dose of 90mg/200g BW improved 
cholesterol levels, LDL levels, Mn-SOD levels and SOD2 gene expression in 
hyperlipidemic rats. 




Hyperlipidemia is a lipid metabolism 
disorder characterized by abnormally elevated 
levels of cholesterol (hypercholesterolemia), 
elevated levels of triglyceride (hypertriglyceri-
demia) or a combination of both in the blood. 
Hyperlipidemia can be a risk factor for various 
degenerative diseases and metabolic syndrome, 
such as atherosclerosis, cardiovascular disease, 
stroke and type 2 diabetes mellitus (Kobayashi et 
al., 2010; Feng et al., 2011; Li  et al., 2013 ; WHO, 
2015). Hyperlipidemia is associated with free 
radical formation (Ismail et al., 2010; Sumardika 
and Jawi, 2012). The formation of free radicals                 
in hyperlipidemic patients occurs through several 
mechanisms, including through increased 
NADH/NADPH oxidase. it leads the formation of 
more superoxide anion radicals that cause 
oxidative stress (Ismail et al., 2010; Sumardika           
and  Jawi,  2012;   Farris  et  al.,  2005).  In  addition,  
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oxidative stress in hyperlipidemic patients can also 
occur due to uncoupling mitochondrial. It also 
causes increased production of free radicals (Farris 
et al., 2005). The compensation mechanism to 
suppress the rate of oxidative stress is with 
antioxidants systems. The body has compensation 
mechanism to the rate of oxidative stress by 
synthesizing enzymes that act as antioxidants, one 
of them superoxide dismutase (SOD). In normal 
condition, the body will balance the formation of 
free radicals with endogenous antioxidant systems. 
However, continuous radical formation makes the 
body unable to inhibits the rate of oxidative            
stress, thus causing pathological conditions. 
Therefore, it is necessary to add certain compounds 
that can help increase endogenous antioxidant 
activity, such as flavonoid compounds (Manach et 
al., 2004). 
 Flavonoids are known to improve 
hyperlipidemia condition and to increase liver 
enzyme levels (Prasetyastuti, 2018). Compound 7-
OH-2-(4-OH-3-methoxyphenyl)-chroman-4-one 
was flavanone (one of flavonoid) compound from 
mahogany seed isolated by Mursiti et al (2015). 
One study found that naringenin, a flavanone in 
diabetic rat model improved hyperglycemia and 
hyperinsulinemia condition significantly by 
restoring lipid level, increasing antioxidant 
activities, and improving liver function markers 
(Prasetyastuti, 2018). Based on this background, 
the aim of this study was to investigate the effects 
of 7-OH-2-(4-OH-3-methoxyphenyl)-chroman-4-
one compounds on cholesterol level, LDL level,             
Mn-SOD levels and SOD2 gene expression of 
hyperlipidemic rats. 
 
MATERIAL AND METHODS 
Hyperlipidemia testing was designed by 
pretest-posttest with control group design and 
both Mn-SOD level and SOD2 gene expression         
were designed by post-test only with control      
group design. Thirty male Wistar rats weighing 
between 150 and 200g, 10 weeks old, were used in 
this study. The location of the research was 
conducted in two laboratories, Biochemistry 
Laboratory Faculty of Medicine, Public Health            
and Nursing Universitas Gadjah Mada and 
Laboratory of Food and Nutrition Universitas 
Gadjah Mada. The experiments were carried            
out according to the guidelines for the use of 
animals and approved by Ethical Committee of 
Research in Medical Health, Faculty of Medicine, 
Public Health, and Nursing Universitas Gadjah Mada 
(No.KE/FK/08/8/EC/2017). 
Animal treatments 
Six experimental rat groups were 
established with 5 rats per group. The groups were 
as follows: group N (normal control group), group 
HL (hyperlipidemia control group), group P 
(hyperlipidemia with simvastatin), group F10 
(hyperlipidemia with 10mg/200g BW of 7-OH-2-
(4-OH-3-methoxyphenyl) chroman-4-one), group 
F30 (hyperlipidemia with 30mg/200g BW of 7-OH-
2-(4-OH-3-methoxyphenyl)-chroman-4-one) and 
group F90 (hyperlipidemia with 90mg/200g BW of 
7-OH-2-(4-OH-3-methoxyphenyl)-chroman-4-one). 
They were fed with standard AIN 93M for 5 days for 
adaptation. Induction of hyperlipidemia was done 
by feeding the animals with laboratory feed 
enriched with 10g/kg cholesterol and 2g/kg cholic 
acid for a week. Fasting blood samples were 
collected to characterization baseline levels of 
cholesterol and LDL. Group N and group HL were 
orally administered by infusion with the same 
volume of water, while the other groups were 
treated with flavonoid once daily for 4 weeks. At 
the end of the experiment, all rats were sacrificed, 
and liver tissues were collected and stored at                  
-80ᵒC for the gene expression study. 
 
Total cholesterol and LDL analysis 
Serum was separated by centrifugation at 
4000rpm for 15min. Total cholesterol and low-
density lipoprotein (LDL)-cholesterol concen-
trations were measured with enzymatic CHOD-PAP 
methods by using Cholesterol FS Diagnostic System 
Kit (German). 
 
Levels of Mn-SOD analysis with Enzyme-Linked 
Immunosorbent Assay (ELISA) 
Levels of Mn- SOD were detected in rat liver 
samples by sandwich ELISA using a ready kit Fine-
Test Kit (Wuhan Fine Biotech Co., Ltd, China) 
according to the instructions of the manufacturer. 
 
Quantitative PCR (qPCR) analysis of SOD2 gene 
expression 
Total mRNA was extracted from rat liver 
with Tri-RNA kits (Favorgen, Biotech                          
Corp, Taiwan) and used to determine the 
expression level of SOD2 gene. Total RNA                       
was converted to cDNA High Capacity cDNA 
Reverse Transcription Kits Protocol (Applied 
Biosystems, USA). Quantitative PCR was performed 
with SoFast Evagreen Supermix (BioRad, USA) 
according to the instructions of the manufacturer. 
The primer sets used are SOD2 forward-5’-
CCCTGACCTGCCTTACGACT-3’ and primer SOD2 
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reverse 5’-AGCGACCTTGCTCCTTATTG-3’ Beta actin 
was used as an internal standard, with primer beta 
actin forward 5’-ACGGTCAGGTCATCACTATCG-3’ 
and beta actin reverse 5’-GGCATAGAGGTCTTTACG 
GATG-3’. For PCR conditions, PCR reaction procedure 
was: 95ᵒC for 5min, followed by 40 cycles of 95ᵒC 
for 30s, and annealing temperature 62ᵒC for 1min 
and extension 72ᵒC for 30s. Relative expression 
levels were calculated using the 2-ΔΔCt method (11) 
(Livak and Schmittgen, 2001). In the present study, 
beta actin was the housekeeping gene.  
 
Statistical analysis 
The data were represented by Mean ±SD. A 
one-way analysis of variance (ANOVA; P<0.05) was 
used to determine significant differences among 
the groups. The variances were homogeneous the 
individual comparisons were obtained by Tukey’s 
HSD post hoc test. If not, the Games-Howell post 
hoc test was applied. Pretest and posttest analysis 
for total cholesterol and LDL concentration used 
paired sample t test. Statistical significance was set 
at P≤0.05.  
 
RESULTS AND DISCUSSION 
Levels of total cholesterol in hyperlipidemia 
rats  
The results showed that cholesterol-induced 
rats (HL group rats) had higher cholesterol levels 
compared with rats in the normal group (N group). 
The daily administration of 7-OH-2-(4-OH-3-
methoxyphenyl)-chroman-4-onee for 4 weeks with 
doses of 10, 30 and 90mg/200g BW can significantly 
decrease cholesterol (p<0.05) (Table I). 
 
Levels of LDL in hyperlipidemia rats  
The levels of LDL increased after induced 
cholesterol fed in the HL group compared with the 
N group (p<0.05). The results showed a significant 
decreased after administration of 7-OH-2-(4-OH-3-




Mean ± SD (mg/dL) 
   pa 
Before After 
N 80.79±7.32 83.69±6.99# b 0.087 
HL  261.35±25.19 263.45±24.29* b 0.041 
P 311.62±29.36 106.99±3.38*# <0.001 
F10 303.87±10.15 167.87±9.70* <0.001 
F30 274.78±33.34 135.90±7.89*# <0.001 
F90 286.33±11.14 113.89±7.77*# <0.001 
 
Description: N: Normal, HL: Hyperlipidemia, P: HL+Simvastatin, F10, F30, F90: HL+ 7-OH-2-(4-OH-3-methoxyphenyl)-
chroman-4-one 10, 30, 90 mg/200g BW respectively. Normality test with Saphiro Wilk; data were tested with Repeated 
measured ANOVA-test p <0.05, a: tested with paired sample t-test. Notation *: p <0.05 vs N; #: p <0.05 vs HL. b: p < 0.05 
vs P 
 




Mean ± SD (mg/dL) 
pa 
Before After 
N 26.79±2.07 27.18±2.26b 0.096 
HL  75.06±4.47 76.24±5.02*b 0.028 
P 74.32±3.10 33.45±1.91*,# <0.001 
F10 70.49±3.39 61.46±2.11*,#b 0.010 
F30 69.13±4.09 43.20±2.03*,# <0.001 
F90 73.33±2.52 37.21±1.68*,# <0.001 
 
Description: N: Normal, HL: Hyperlipidemia, P: HL+Simvastatin, F10, F30, F90: HL+ 7-OH-2-(4-OH-3-methoxyphenyl)-
chroman-4-one 10, 30, 90 mg/200g BW respectively. Normality test with Saphiro Wilk; data were tested with Repeated 
measured ANOVA-test p<0.05, a: tested with paired sample t-test. Notation *: p <0.05 vs N; #: p <0.05 vs HL. b: p < 0,05 
vs P 
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methoxyphenyl)-chroman-4-one at a dose of 10, 30 
and 90 mg/200g BW in each group (Table II). 
 
C. Levels of Mn-SOD proteins 
The rats fed on high-cholesterol diet (HL 
group) exhibited a significant elevation in Mn-SOD 
levels compared with N group. After being induced, 
the administration of 7-hydroxy-2-(4-hydroxy-3-
methoxyphenyl)-chroman-4-one for 4 weeks in 
hyperlipidemic rats liver showed a significant 
difference between hyperlipidemia group and F30, 
F90, and treatment group. However, there was no 





Figure 1. Level of Mn-SOD protein Group, 
Description: N: Normal, HL: Hyperlipidemia, P: 
HL+Simvastatin, F10, F30, F90: HL+ 7-OH-2-(4-OH-
3-methoxyphenyl)-chroman-4-one 10, 30, 90 
mg/200g BW respectively. Normality test with 
Saphiro Wilk; data were tested with ANOVA-test p 
<0.05. Notation *: p <0.05 vs N; #: p <0.05 vs HL. 
 
Relative expression of SOD2 gene  
The relative gene expression of SOD2 used 
beta actin for housekeeping gene (Figure 2). The 
results of the study based on statistics there was no 
significant difference between the groups. 
However, in F90 has relative expression value 
almost approaching with N group. 
The results of cholesterol and LDL 
cholesterol levels showed a significant decrease              
in cholesterol levels of hyperlipidemia rats               
before and after administration of 7-OH-2-(4-OH-
3-methoxyphenyl)-chroman-4-one   in    all   doses. 
However, the best decline occurred in group                    
6 rats, which were given 7-OH-2-(4-OH-3-
methoxyphenyl)-chroman-4-one dose of 90 
mg/200g BW. Based on the results of statistical 
analysis, a best dose is 90 mg/200g BW that have 
same effect with simvastatin 0.18 mg/200g BW to 
improve lipid level in blood. 
 
 
Figure 2. Relative gene expression of SOD2                  
gene, Description: N: Normal, HL: Hyperlipidemia, 
P: HL+Simvastatin, F10, F30, F90: HL+ 7-OH-2-              
(4-OH-3-methoxyphenyl)-chroman-4-one 10, 30, 
90mg/200g BW respectively. Normality test with 
Saphiro Wilk; data were tested with ANOVA-test p 
>0.05.  
 
The decreased levels of cholesterol and            
LDL by daily administration of 7-OH-2-(4-OH-3-
methoxyphenyl)-chroman-4-one compound was in 
accordance with some studies. Study of Gorinstein 
et al.(2007) showed that naringin and hesperidin, 
which are flavanone compound as 7-OH-2- (4-OH-
3-methoxyphenyl)-chroman-4-one, could decrease 
and preclude the plasma lipid. Jayachitra and Nalini 
(2011) also revealed that naringenin could hinder 
high plasma lipid and lipoprotein by alcohol 
induction. As with Prince and Kannan (2006) that 
the effects of flavonoid compounds Rutin can 
reduce cholesterol and LDL levels. The results of 
Feng et al. (2011) also showed that flavonoid 
content in Perilla Frutescens leaves can also lower 
cholesterol and LDL levels in the blood.  
Decrease in cholesterol and LDL levels in the 
blood occurs through several mechanisms 
including what were stated by Jayachitra and  
Nalini (2011) that Flavonoid, such as naringenin 
could inhibit HMG-CoA reductase activity while 
HMG CoA is a rate limiting step of cholesterol 
biosynthesis. Choi et al. (2008) conducted that   
flavonoids   can   lower cholesterol levels    by 
inhibition and decrease activity of Acyl-coenzyme 
A: cholesterol acyltransferase (ACAT), is an enzyme 
involved in cholesterol esterification and has a role 
in cholesterol absorption in the intestinal. 
Inhibition of HMG CoA reductase and ACAT reduce 
cellular hepatic cholesterol level. It induced 
expression and upregulated LDL Receptor for 
entered LDL-c as vehicle cholesterol in blood by 
activating SREBP-2 as transcription factor for LDLR 
(Duriez, 2003; Wilcox et al., 2001). This 
mechanisme like naringenin and hesperidine, 
effect of induced naringenin and hesperidine 
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inhibited apoB secretion and upregulated 
expression of LDLR (Wilcox et al., 2001). In 
addition, according to Koo and Noh (Koo and Noh, 
2007) flavonoids also play a role in lowering LDL 
and cholesterol levels through inhibition of 
cholesterol absorption in the small intestine and 
can increase bile excretion (Gorinstein et al., 2005). 
The result of analysis levels Mn-SOD 
fproteins o hepatic tissue was highest in group 2 
(hyperlipidemia group). Increased protein levels in 
the hyperlipidemia group compared to the normal 
group according to Akhgari et al. (2003) due to the 
activated mechanism of body compensation for 
oxidative stress caused by hyperlipidemia. High 
lipid level altered  lipid properties in lipid raft, and 
activated NADPH oxidase to produce ROS. High 
Lipid also decrease antioxidant enzyme activity 
(Amiya, 2016). The ability of the body to 
compensate for the presence of free radicals is also 
influenced by several factors, such as the 
magnitude of oxidative stress and the dose of the 
stressor (Chen et al., 2014).   
After the administration of 7-OH-2-(4-OH-3-
methoxyphenyl) -chroman-4-one for 4 weeks, in 
the group given 90 mg/200g BW (group 6) there 
was a significant decrease in Mn-SOD levels 
compared to the hyperlipidemia group (p<0,05), 
but the Mn-SOD levels in this group did not 
significantly different compared to the normal 
group and the simvastatin group (p>0.05). This is 
because flavonoid compounds can act as 
scavengers by directly donating their hydrogen 
atoms in order to reduce the reactivity of free 
radicals without passing through inducing 
antioxidant enzymes (Redha, 2010). The reduction 
of free radicals due to direct neutralization by the 
flavonoid compound causes a decrease in the rate 
of oxidative stress, so the synthesis of antioxidant 
enzymes will decrease (Chen et al., 2014) 
The results of SOD2 gene expression 
analysis showed that there was no significant 
difference between the groups. The highest 
expression values were in the hyperlipidemic 
group. This shows that indeed in this study the 
body is still able to compensate by increasing the 
level of expression of SOD2 to respond to oxidative 
stress (Redha, 2010). The presence of oxidative 
stress signals will cause cell response that is by 
triggering transcription factor Nrf2 regardless of 
the Keap1 binding protein. The absence of Nrf2 
from Keap1 causes Nrf2 transmigrated from the 
cytoplasm to the nucleus. Nrf2 in the nucleus will 
bind to the antioxidant element response (ARE) 
thus increasing the expression of the SOD2 gene 
(Khaerunnisa et al., 2014; Vomhof-DeKrey and 
Picklo, 2012).  
The analysis compared between the groups 
given the 7-OH-2-(4-OH-3-methoxyphenyl)-
chroman-4-one, the group with the dose of 90 
mg/200g BW (group 6) had the lowest fold change 
value among the other groups, it was close to 
normal group values and simvastatin. The pattern 
was similar to its protein content. Decreased levels 
of gene expression that given 7-OH-2-(4-OH-3-
methoxyphenyl)-chroman-4-one compared to 
hyperlipidemia group according to Feng et al. 
(2011) and supported by Martin et al. (2010) that 
flavonoid compounds in the main role as scavenger, 
they have the ability to eliminate directly some 
radicals, such as superoxide anion, hydroxyl 
radicals and peroxyl radicals and indirectly 
increase expression and activity of endogenous 
antioxidant for scavenger ROS (Zeka et al., 2017).  
The result of Mn-SOD concentration in this 
study was the same as Khaerunnisa et al. studied 
(2014) using extract from reeds (Imperata 
cylindrical) in hypercholesterolemia rat. The result 
shows that the induction of hypercholesterol for 3 
weeks increases the activity of SOD as a result of the 
compensation mechanism of the body, after the 
feeding of extract of reeds the SOD activity has 
decreased, due to the bioactive compounds in reeds 
extract play directly in neutralizing superoxide 
radicals (Vomhof-DeKrey and Picklo, 2012).  
However, in the research of Liu and Lin 
(2011) used a quercetin to treat the animals. After 
animals were treated for 10 weeks, there was an 
increase in SOD levels in quercetin group compared 
with hyperlipidemic rats group. Miler et al., (2016)  
conducted   that   naringenin  increased expression 
both mRNA and protein of SOD2 by prooxidant 
activity of naringenin. Because naringenin can form 
flavonoid radical and stimulated secretion SOD2 
enzyme.  
   
CONCLUSION 
Administration of 7-OH-2-(4-OH-3-
methoxyphenyl)-chroman-4-one at a effective dose 
of 30mg/200g BW can decrease cholesterol and 
LDL levels in serum hyperlipidemia and can also 
improve the levels of Mn-SOD in rats. But there was 
no significant effect on gene expression of SOD2 
liver in hyperlipidemic rats. 
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